SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTI-PHOSPHOLIPID SYNDROMEE60. NEW OPHTHALMIC MONITORING OF HYDROXYCHLOROQUINE: WILL THIS LEAD TO MORE PATIENTS HAVING THEIR TREATMENT STOPPED?

Authors :: R. Gale
S. Mackenzie
S. Smrity
A. Gough
G. Walters
A. Benson
R. Gupta
Michael J. Green
Source :: Rheumatology. 56
Publication Year :: 2017
Publisher :: Oxford University Press (OUP), 2017.

Subjects :: medicine.medical_specialty
Rheumatology
business.industry
Medicine
Pharmacology (medical)
Hydroxychloroquine
business
Lead (electronics)
Dermatology
medicine.drug
Anti phospholipid antibodies

Tools